M. Johannessen

The effect of polymerised fibrin on the catalytic activities of one-chain tissue-type plasminogen activator as revealed by an analogue resistant to plasmin cleavage.

E. Mulvihill, L. Petersen, D. Foster, 1988, Biochimica et biophysica acta.

Effect of recombinant factor VIIa (Novoseven) on thrombocytopenia-like conditions in vitro.

U. Hedner, M. Johannessen, M. Kjalke, 2001, Seminars in hematology.

Pharmacokinetics and Safety of FFR‐rFVIIa after Single Doses in Healthy Subjects

E. Erhardtsen, M. Thomsen, M. Johannessen, 2001, Journal of clinical pharmacology.

Comparison of the factor VII:C clot analysis and a modified activated factor VII analysis for monitoring factor VII activity in patients treated with recombinant activated factor VII (NovoSeven®)

O. Nordfang, M. Johannessen, G. Nielsen, 2000, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Quenching of the amidolytic activity of one-chain tissue-type plasminogen activator by mutation of lysine-416.

E. Boel, L. Petersen, D. Foster, 1990, Biochemistry.

Plasmin-catalysed cleavage of single chain tissue-type plasminogen activator in fibrin clots

L. Petersen, M. Johannessen, F. Nielsen, 1989 .

Decline of factor VIII and factor IX inhibitors during long-term treatment with NovoSeven.

O. Nordfang, M. Johannessen, R. Andreasen, 2000, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Relations between blood, sinus fluid and lymph in Myxine glutinosa L.

K. Johansen, M. Johannessen, R. Fánge, 1962, Comparative biochemistry and physiology.

Fibrin Affinity and Clearance of t-PA Deletion and Substitution Analogues

E. Mulvihill, L. Petersen, P. O'Hara, 1990, Thrombosis and Haemostasis.

64 Recombinant tPA deletion analogues: activity, fibrin binding and clearance studies

E. Mulvihill, L. Petersen, M. Johannessen, 1988 .